Combination LSD1 and HOTAIR-EZH2 inhibition disrupts cell cycle processes and induces apoptosis in glioblastoma cells
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combination LSD1 and HOTAIR-EZH2 inhibition disrupts cell cycle processes and induces apoptosis in glioblastoma cells
Authors
Keywords
HOTAIR, AQB, LSD1, CDKN1A, BBC3
Journal
PHARMACOLOGICAL RESEARCH
Volume 171, Issue -, Pages 105764
Publisher
Elsevier BV
Online
2021-07-09
DOI
10.1016/j.phrs.2021.105764
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Author Correction: Gene regulation by long non-coding RNAs and its biological functions
- (2021) Luisa Statello et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Targeting apoptosis in cancer therapy
- (2020) Benedito A. Carneiro et al. Nature Reviews Clinical Oncology
- Pharmacologic inhibition of lysine-specific demethylase 1 as a therapeutic and immune-sensitization strategy in pediatric high-grade glioma
- (2020) Cavan P Bailey et al. NEURO-ONCOLOGY
- Epigenetic Therapies for Cancer
- (2020) Susan E. Bates NEW ENGLAND JOURNAL OF MEDICINE
- Epigenomic Reprogramming as a Driver of Malignant Glioma
- (2020) Richard E. Phillips et al. CANCER CELL
- Lsd1 as a therapeutic target in Gfi1-activated medulloblastoma
- (2019) Catherine Lee et al. Nature Communications
- LSD1 suppresses invasion, migration and metastasis of luminal breast cancer cells via activation of GATA3 and repression of TRIM37 expression
- (2019) Xin Hu et al. ONCOGENE
- RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGFβ pathway-dependent manner
- (2019) Kai Zhao et al. Cell Death & Disease
- LSD1/KDM1A inhibitors in clinical trials: advances and prospects
- (2019) Yuan Fang et al. Journal of Hematology & Oncology
- LSD1 inhibition exerts its antileukemic effect by recommissioning PU.1- and C/EBPα-dependent enhancers in AML
- (2018) Monica Cusan et al. BLOOD
- Ironing out the role of the cyclin-dependent kinase inhibitor, p21 in cancer: Novel iron chelating agents to target p21 expression and activity
- (2018) Rayan S. Moussa et al. FREE RADICAL BIOLOGY AND MEDICINE
- Primary brain tumours in adults
- (2018) Sarah Lapointe et al. LANCET
- Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor
- (2018) Huimin Hu et al. CELL
- Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma
- (2017) Roger Stupp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma
- (2017) James R. Perry et al. NEW ENGLAND JOURNAL OF MEDICINE
- p21: A Two-Faced Genome Guardian
- (2017) Alexandros G. Georgakilas et al. TRENDS IN MOLECULAR MEDICINE
- Long Noncoding RNAs in Cancer Pathways
- (2016) Adam M. Schmitt et al. CANCER CELL
- Survival in glioblastoma: a review on the impact of treatment modalities
- (2016) P. D. Delgado-López et al. Clinical & Translational Oncology
- A Systematic Review of Histone Lysine-Specific Demethylase 1 and Its Inhibitors
- (2015) Yi-Chao Zheng et al. MEDICINAL RESEARCH REVIEWS
- Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expression
- (2015) David Kozono et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Long non-coding RNA HOTAIR promotes glioblastoma cell cycle progression in an EZH2 dependent manner
- (2015) Kailiang Zhang et al. Oncotarget
- The Polyamine Catabolic Enzyme SAT1 Modulates Tumorigenesis and Radiation Response in GBM
- (2014) A. Brett-Morris et al. CANCER RESEARCH
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- Control of cell cycle transcription during G1 and S phases
- (2013) Cosetta Bertoli et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- PKM2 Phosphorylates Histone H3 and Promotes Gene Transcription and Tumorigenesis
- (2012) Weiwei Yang et al. CELL
- Inhibition of Histone Deacetylation Potentiates the Evolution of Acquired Temozolomide Resistance Linked to MGMT Upregulation in Glioblastoma Xenografts
- (2012) G. J. Kitange et al. CLINICAL CANCER RESEARCH
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
- (2010) Rajnish A. Gupta et al. NATURE
- Long Noncoding RNA as Modular Scaffold of Histone Modification Complexes
- (2010) M.-C. Tsai et al. SCIENCE
- PUMA, a potent killer with or without p53
- (2009) J Yu et al. ONCOGENE
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started